Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Nutrients
|
August 9, 2019
A Dietary Intervention of Bioactive Enriched Foods Aimed at Adults at Risk of Metabolic Syndrome: Protocol and Results from PATHWAY-27 Pilot Study
Achim Bub, Corinne Malpuech-Brugère, Caroline Orfila, et al.
Annals of the Rheumatic Diseases
|
August 14, 2015
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
Walter P Maksymowych, Maxime Dougados, Désirée van der Heijde, et al.
Brain Stimulation
|
October 6, 2009
Consensus: "Can tDCS and TMS enhance motor learning and memory formation?"
Janine Reis, Edwin Robertson, John W Krakauer, et al.
Arthritis Care & Research
|
May 9, 2017
Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study
Maxime Dougados, Désirée van der Heijde, Joachim Sieper, et al.
Brain Stimulation
|
July 17, 2010
Consensus: Can transcranial direct current stimulation and transcranial magnetic stimulation enhance motor learning and memory formation?
Janine Reis, Edwin M Robertson, John W Krakauer, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Discovery and Characterization of Zelnecirnon (RPT193), a Potent and Selective CCR4 Antagonist for Allergic Disorders
Mikhail Zibinsky, Delia Bradford, Dirk G Brockstedt, et al.
Journal of Medicinal Chemistry
|
July 16, 2020
Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors
Omar Robles, Jeffrey J Jackson, Lisa Marshall, et al.
Physiotherapy Canada. Physiotherapie Canada
|
February 4, 2016
[Not Available]
Lucie Brosseau, Chantal Laroche, Anne Sutton, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2018
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
Asha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, et al.
Journal of Medicinal Chemistry
|
July 2, 2019
Discovery of a Potent and Selective CCR4 Antagonist That Inhibits T<sub>reg</sub> Trafficking into the Tumor Microenvironment
Jeffrey J Jackson, John M Ketcham, Ashkaan Younai, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Nutrients
|
August 9, 2019
A Dietary Intervention of Bioactive Enriched Foods Aimed at Adults at Risk of Metabolic Syndrome: Protocol and Results from PATHWAY-27 Pilot Study
Achim Bub, Corinne Malpuech-Brugère, Caroline Orfila, et al.
Annals of the Rheumatic Diseases
|
August 14, 2015
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
Walter P Maksymowych, Maxime Dougados, Désirée van der Heijde, et al.
Brain Stimulation
|
October 6, 2009
Consensus: "Can tDCS and TMS enhance motor learning and memory formation?"
Janine Reis, Edwin Robertson, John W Krakauer, et al.
Arthritis Care & Research
|
May 9, 2017
Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study
Maxime Dougados, Désirée van der Heijde, Joachim Sieper, et al.
Brain Stimulation
|
July 17, 2010
Consensus: Can transcranial direct current stimulation and transcranial magnetic stimulation enhance motor learning and memory formation?
Janine Reis, Edwin M Robertson, John W Krakauer, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Discovery and Characterization of Zelnecirnon (RPT193), a Potent and Selective CCR4 Antagonist for Allergic Disorders
Mikhail Zibinsky, Delia Bradford, Dirk G Brockstedt, et al.
Journal of Medicinal Chemistry
|
July 16, 2020
Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors
Omar Robles, Jeffrey J Jackson, Lisa Marshall, et al.
Physiotherapy Canada. Physiotherapie Canada
|
February 4, 2016
[Not Available]
Lucie Brosseau, Chantal Laroche, Anne Sutton, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2018
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
Asha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, et al.
Journal of Medicinal Chemistry
|
July 2, 2019
Discovery of a Potent and Selective CCR4 Antagonist That Inhibits T<sub>reg</sub> Trafficking into the Tumor Microenvironment
Jeffrey J Jackson, John M Ketcham, Ashkaan Younai, et al.
Page
of 11